Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
Oligonucleotide-based therapies are advanced novel interventions used in the management
of various respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease …
of various respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease …
Peptide/protein vaccine delivery system based on PLGA particles
M Allahyari, E Mohit - Human vaccines & immunotherapeutics, 2016 - Taylor & Francis
abstract Due to the excellent safety profile of poly (D, L-lactide-co-glycolide)(PLGA) particles
in human, and their biodegradability, many studies have focused on the application of PLGA …
in human, and their biodegradability, many studies have focused on the application of PLGA …
Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine
JI Andorko, CM Jewell - Bioengineering & translational …, 2017 - Wiley Online Library
Recent research in the vaccine and immunotherapy fields has revealed that biomaterials
have the ability to activate immune pathways, even in the absence of other immune …
have the ability to activate immune pathways, even in the absence of other immune …
Nanovaccine‐based strategies to overcome challenges in the whole vaccination cascade for tumor immunotherapy
L Qin, H Zhang, Y Zhou, CS Umeshappa, H Gao - Small, 2021 - Wiley Online Library
Nanovaccine‐based immunotherapy (NBI) has received greater attention recently for its
potential to prime tumor‐specific immunity and establish a long‐term immune memory that …
potential to prime tumor‐specific immunity and establish a long‐term immune memory that …
Recent applications and strategies in nanotechnology for lung diseases
W Zhong, X Zhang, Y Zeng, D Lin, J Wu - Nano Research, 2021 - Springer
Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …
PLGA particles in immunotherapy
D Horvath, M Basler - Pharmaceutics, 2023 - mdpi.com
Poly (lactic-co-glycolic acid)(PLGA) particles are a widely used and extensively studied drug
delivery system. The favorable properties of PLGA such as good bioavailability, controlled …
delivery system. The favorable properties of PLGA such as good bioavailability, controlled …
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International journal of nanomedicine, 2017 - Taylor & Francis
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
Nanoparticle-based delivery of CRISPR/Cas9 genome-editing therapeutics
The recent progress in harnessing the efficient and precise method of DNA editing provided
by CRISPR/Cas9 is one of the most promising major advances in the field of gene therapy …
by CRISPR/Cas9 is one of the most promising major advances in the field of gene therapy …
Inhaled drug delivery for the targeted treatment of asthma
Asthma is a chronic lung disease affecting millions worldwide. While classically
acknowledged to result from allergen-driven type 2 inflammatory responses leading to IgE …
acknowledged to result from allergen-driven type 2 inflammatory responses leading to IgE …
Immunomodulatory effects of subacute inhalation exposure to copper oxide nanoparticles in house dust mite-induced asthma
S Areecheewakul, A Adamcakova-Dodd… - ACS …, 2023 - ACS Publications
It has been shown that inhalation exposure to copper oxide nanoparticles (CuO NPs) results
in pulmonary inflammation. However, immunomodulatory consequences after CuO NP …
in pulmonary inflammation. However, immunomodulatory consequences after CuO NP …